Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-11.73	54.40	61.64
Graham Fair Price	16.05	19.75	17.02
PEG	-79.78	0.75	-3.72
Price/Book	-0.33	3.05	3.06
Price/Cash Flow	541.15	-58.50	9.12
Prices/Earnings	-20.81	23.77	30.02
Price/Sales	0.71	20.09	19.95
Price/FCF	541.15	-58.50	9.12
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	2.18	0.74	0.73
Operating Margin	23.61	0.38	0.31
ROA	37.78	< 0.005	< 0.005
ROE	0.03	0.03	25.87
ROIC	0.02	0.02	12.54
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.08	-0.07	-20.35
Dividends QOQ	0.02	-0.02	0.01
EBIT QOQ	-0.10	0.27	170.54
EPS QOQ	-0.08	0.32	291.58
FCF QOQ	2.15	-1.16	-46.01
Revenue QOQ	-0.02	0.02	51.05
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	1052.31	993.36	-5.60
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.59	0.57	-4.35
Quick Ratio	13.59	10.89	-19.88
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	22.47	23.24	3.44
Cash	37.07	27.05	-27.02
Capex	-0.03	-0.08	-136.25
Free Cash Flow	7.54	-1.21	-83.92
Revenue	3.45	3.53	2.37
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	4.17	2.87	-31.26
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	7.21	8.36	15.89
Naive Interpretation	Member

06 - Financial Health · Bad

Rating